Synonyms: Ro-109359 | Tegison®
etretinate is an approved drug (FDA (1986))
Compound class:
Synthetic organic
Comment: Etretinate is a highly lipophilic second-generation retinoid. Its use has largely been discontinued as it was discovered to be a long-acting teratogen, with detectable levels in plasma up to three years post-therapy.
![]() View more information in the IUPHAR Pharmacology Education Project: etretinate |
|
Bioactivity Comments |
We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target. |